Patent settlements saved Americans $25.5bn, report shows
This article was originally published in SRA
Executive Summary
Patent settlements in the US between branded and generic drug manufacturers saved consumers and the nation's healthcare system $25.5 billion from 2005-2012, according to a report that adds to the debate over whether such settlements save or raise costs for patients and payers1,2.